Todas as matérias desta seção, das mais recentes às mais antigas — página 259 de 371.
Legend Biotech (NASDAQ:LEGN) reported a transformative fourth quarter and full year for 2025, headlined by the commercial success of its lead CAR-T therapy, CARVYKTI®.
Oracle (NYSE:ORCL) delivered third-quarter fiscal 2026 results on Tuesday that exceeded Wall Street expectations, bolstered by a massive wave of demand for its artificial intelligence (AI) cloud infrastructure.
Franco-Nevada (NYSE:FNV), the gold-focused royalty and streaming company, reported record-breaking financial results for the fiscal year ended December 31, 2025.
Veeva Systems (NYSE:VEEV) announced on Tuesday the acquisition of Ostro, a premier brand engagement platform tailored for the life sciences industry.
MIND CTI (NASDAQ:MNDO), a leading provider of convergent billing and customer care product-based solutions for service providers, announced its fourth-quarter and full-year financial results for 2025 on Tuesday.
Meta Platforms (NASDAQ:META) announced on Tuesday the acquisition of Moltbook, a niche but rapidly growing social networking platform designed specifically for artificial intelligence agents.
Optical Cable (NASDAQ:OCC), a leading manufacturer of a broad range of fiber optic and copper data communication cabling and connectivity solutions, today announced financial results for its first quarter of fiscal year 2026, which ended January 31, 2026.
Nuwellis (NASDAQ:NUWE), a commercial-stage medical device company focused on transforming the care of patients with fluid overload, reported fourth-quarter 2025 revenue of $2.4 million on Tuesday.
SS Innovations International (NASDAQ:SSII), the developer of the SSi Mantra™—the first surgical robotic system to be commercially available in India—reported explosive growth for the fiscal year ended December 31, 2025.
Laser Photonics (NASDAQ:LASE), a leading industrial developer of high-power laser systems for cleaning and material processing, announced preliminary, unaudited financial results for the fiscal year ended December 31, 2025.
Ideal Power (NASDAQ:IPWR), the pioneer behind the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reported fourth-quarter and full-year 2025 financial results on Tuesday.
Edgewise Therapeutics (NASDAQ:EWTX), a clinical-stage biopharmaceutical company developing orally bioavailable small molecules for rare muscle disorders, announced positive long-term results from its MESA open-label extension study of sevasemten.
Custom Truck One Source (NYSE:CTOS), a premier provider of specialty equipment to the electric utility, telecommunications, and rail markets, reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.
ADC Therapeutics (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation antibody-drug conjugates (ADCs), reported a steady fourth quarter for 2025 and a significantly strengthened balance sheet on Tuesday.
Priority Technology Holdings (NASDAQ:PRTH), a payments and banking fintech, reported robust financial results for the fourth quarter of 2025 on Tuesday.
Inspired Entertainment (NASDAQ:INSE) reported a transformative fourth quarter for 2025, underscored by a decisive shift toward its high-growth digital segments.
BioNTech (NASDAQ:BNTX), the biotechnology firm that rose to global prominence with its COVID-19 vaccine, reported full-year 2025 revenues of €2.87 billion on Tuesday.
Ultralife (NASDAQ:ULBI), a global provider of advanced high-energy power and communications systems, reported a net loss of $7.4 million for its fourth quarter on Tuesday.
Apyx Medical (NASDAQ:APYX), an advanced energy technology company proprietary to the Renuvion® helium plasma platform, reported a net loss of $1.3 million for its fourth quarter on Tuesday.
KVH Industries (NASDAQ:KVHI), a global leader in mobile connectivity and inertial navigation systems, reported a net profit of $331,000 for its fourth quarter on Tuesday.
Lipocine (NASDAQ:LPCN), a specialty pharmaceutical company focused on developing oral delivery solutions for endocrine and metabolic disorders, reported a net loss of $2.4 million for the fourth quarter on Tuesday.
Willis Lease Finance (NASDAQ:WLFC), a leading lessor of commercial jet engines and a provider of aviation services, reported a net profit of $10.8 million for the fourth quarter on Tuesday.
Q32 Bio (NASDAQ:QTTB), a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory diseases, provided a fourth-quarter 2025 corporate update that highlights a significantly strengthened balance sheet and clinical progress.
United Natural Foods (NYSE:UNFI), the largest publicly traded wholesale distributor of health and specialty foods in North America, reported a significant increase in profitability for its fiscal second quarter ended January 31, 2026.
